Article Information
History
- December 29, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nayra M. Al-Thani1,2,
- Shaza B Zaghlool2,
- Abdul Badi Abou-Samra3,
- Karsten Suhre2,4,*,# and
- Omar M E Albagha1,5,*,#
- 1College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Education City, Doha, Qatar
- 2Bioinformatics Core, Weill Cornell Medicine-Qatar, Education City, 24144 Doha, Qatar
- 3Qatar Metabolic Institute, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar
- 4Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10021, USA
- 5Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, United Kingdom
- ↵*Corresponding author: Correspondence and material requests should be addressed to: Dr. Omar M E Albagha Hamad Bin Khalifa University PO Box 34110, Doha, Qatar, E-mail: oalbagha{at}hbku.edu.qa Tel: + 974 44542974 Or Dr. Karsten Suhre, Weill Cornell Medicine-Qatar PO Box 24144, Doha, Qatar, E-mail: kas2049{at}med.cornell.edu Tel: +97444928482
Posted December 29, 2024.
Subtyping of Type 2 Diabetes from a large Middle Eastern Biobank: Implications for Precision Medicine
